Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Macropinocytosis contributes to hantavirus entry into human airway epithelial cells.

Torriani G, Mayor J, Zimmer G, Kunz S, Rothenberger S, Engler O.

Virology. 2019 May;531:57-68. doi: 10.1016/j.virol.2019.02.013. Epub 2019 Feb 21.

PMID:
30852272
2.

Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Torriani G, Trofimenko E, Mayor J, Fedeli C, Moreno H, Michel S, Heulot M, Chevalier N, Zimmer G, Shrestha N, Plattet P, Engler O, Rothenberger S, Widmann C, Kunz S.

J Virol. 2019 Mar 5;93(6). pii: e01744-18. doi: 10.1128/JVI.01744-18. Print 2019 Mar 15.

PMID:
30626681
3.

Standardized focus assay protocol for biosafety level four viruses.

Ackermann-Gäumann R, Siegrist D, Züst R, Signer J, Lenz N, Engler O.

J Virol Methods. 2019 Feb;264:51-54. doi: 10.1016/j.jviromet.2018.12.002. Epub 2018 Dec 1.

PMID:
30513365
4.

Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections.

Remy MM, Alfter M, Chiem MN, Barbani MT, Engler OB, Suter-Riniker F.

Clin Microbiol Infect. 2019 Jul;25(7):907.e7-907.e12. doi: 10.1016/j.cmi.2018.10.016. Epub 2018 Oct 28.

5.

Host switching pathogens, infectious outbreaks and zoonosis: A Marie Skłodowska-Curie innovative training network (HONOURs).

van der Hoek L, Verschoor E, Beer M, Höper D, Wernike K, Van Ranst M, Matthijnssens J, Maes P, Sastre P, Rueda P, Drexler JF, Barr J, Edwards T, Millner P, Vermeij P, de Groof A, Thiel V, Dijkman R, Suter-Riniker F, Leib S, Koller R, Ramette A, Engler O, Beuret C.

Virus Res. 2018 Sep 15;257:120-124. doi: 10.1016/j.virusres.2018.09.002.

6.

Evaluation of antivirals against tick-borne encephalitis virus in organotypic brain slices of rat cerebellum.

Lenz N, Engler O, Grandgirard D, Leib SL, Ackermann-Gäumann R.

PLoS One. 2018 Oct 9;13(10):e0205294. doi: 10.1371/journal.pone.0205294. eCollection 2018.

7.

The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor.

García-Nicolás O, V'kovski P, Vielle NJ, Ebert N, Züst R, Portmann J, Stalder H, Gaschen V, Vieyres G, Stoffel M, Schweizer M, Summerfield A, Engler O, Pietschmann T, Todt D, Alves MP, Thiel V, Pfaender S.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01206-18. doi: 10.1128/AAC.01206-18. Print 2018 Nov.

8.

Hantavirus Cardiopulmonary Syndrome Due to Imported Andes Hantavirus Infection in Switzerland: A Multidisciplinary Challenge, Two Cases and a Literature Review.

Kuenzli AB, Marschall J, Schefold JC, Schafer M, Engler OB, Ackermann-Gäumann R, Reineke DC, Suter-Riniker F, Staehelin C.

Clin Infect Dis. 2018 Nov 13;67(11):1788-1795. doi: 10.1093/cid/ciy443.

9.

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.

Huttner A, Agnandji ST, Combescure C, Fernandes JF, Bache EB, Kabwende L, Ndungu FM, Brosnahan J, Monath TP, Lemaître B, Grillet S, Botto M, Engler O, Portmann J, Siegrist D, Bejon P, Silvera P, Kremsner P, Siegrist CA; VEBCON; VSV-EBOVAC; VSV-EBOPLUS Consortia.

Lancet Infect Dis. 2018 Jul;18(7):738-748. doi: 10.1016/S1473-3099(18)30165-8. Epub 2018 Apr 5.

10.

Conserved Endonuclease Function of Hantavirus L Polymerase.

Rothenberger S, Torriani G, Johansson MU, Kunz S, Engler O.

Viruses. 2016 May 2;8(5). pii: E108. doi: 10.3390/v8050108.

11.

A tick-borne encephalitis model in infant rats infected with langat virus.

Maffioli C, Grandgirard D, Engler O, Leib SL.

J Neuropathol Exp Neurol. 2014 Dec;73(12):1107-15. doi: 10.1097/NEN.0000000000000131.

PMID:
25383637
12.

The microbial detection array for detection of emerging viruses in clinical samples--a useful panmicrobial diagnostic tool.

Rosenstierne MW, McLoughlin KS, Olesen ML, Papa A, Gardner SN, Engler O, Plumet S, Mirazimi A, Weidmann M, Niedrig M, Fomsgaard A, Erlandsson L.

PLoS One. 2014 Jun 25;9(6):e100813. doi: 10.1371/journal.pone.0100813. eCollection 2014.

13.

Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity.

Engler O, Klingstrom J, Aliyev E, Niederhauser C, Fontana S, Strasser M, Portmann J, Signer J, Bankoul S, Frey F, Hatz C, Stutz A, Tschaggelar A, Mutsch M.

Euro Surveill. 2013 Dec 12;18(50):20660. No abstract available.

14.

European surveillance for West Nile virus in mosquito populations.

Engler O, Savini G, Papa A, Figuerola J, Groschup MH, Kampen H, Medlock J, Vaux A, Wilson AJ, Werner D, Jöst H, Goffredo M, Capelli G, Federici V, Tonolla M, Patocchi N, Flacio E, Portmann J, Rossi-Pedruzzi A, Mourelatos S, Ruiz S, Vázquez A, Calzolari M, Bonilauri P, Dottori M, Schaffner F, Mathis A, Johnson N.

Int J Environ Res Public Health. 2013 Oct 11;10(10):4869-95. doi: 10.3390/ijerph10104869. Review.

15.

[En route in Switzerland - tick-borne and hantavirus infections].

Schmid S, Aliyev E, Engler O, Mütsch M.

Ther Umsch. 2013 Jun;70(6):353-8. doi: 10.1024/0040-5930/a000416. Review. German.

PMID:
23732453
16.

SiRNA inhibits replication of Langat virus, a member of the tick-borne encephalitis virus complex in organotypic rat brain slices.

Maffioli C, Grandgirard D, Leib SL, Engler O.

PLoS One. 2012;7(9):e44703. doi: 10.1371/journal.pone.0044703. Epub 2012 Sep 12.

17.

A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010.

Heyman P, Ceianu CS, Christova I, Tordo N, Beersma M, João Alves M, Lundkvist A, Hukic M, Papa A, Tenorio A, Zelená H, Essbauer S, Visontai I, Golovljova I, Connell J, Nicoletti L, Van Esbroeck M, Gjeruldsen Dudman S, Aberle SW, Avšić-Županc T, Korukluoglu G, Nowakowska A, Klempa B, Ulrich RG, Bino S, Engler O, Opp M, Vaheri A.

Euro Surveill. 2011 Sep 8;16(36). pii: 19961.

18.

Liposome-based vaccines.

Schwendener RA, Ludewig B, Cerny A, Engler O.

Methods Mol Biol. 2010;605:163-75. doi: 10.1007/978-1-60327-360-2_11.

PMID:
20072880
19.

Clinical and immune response to undiluted and diluted smallpox vaccine.

Gassmann R, Engler OB, Steffen R, Alex M, Czerny CP, Mutsch M.

Swiss Med Wkly. 2008 Jul 12;138(27-28):392-7. doi: 2008/27/smw-11966.

20.

Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.

Beeler A, Engler O, Gerber BO, Pichler WJ.

J Allergy Clin Immunol. 2006 Feb;117(2):455-62.

PMID:
16461148
21.

Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins.

Wölk B, Gremion C, Ivashkina N, Engler OB, Grabscheid B, Bieck E, Blum HE, Cerny A, Moradpour D.

J Gen Virol. 2005 Jun;86(Pt 6):1737-46.

PMID:
15914852
22.

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.

Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, Zurbriggen R.

Int Immunol. 2005 Jun;17(6):695-704. Epub 2005 Apr 20.

PMID:
15843436
23.

A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins.

Engler OB, Schwendener RA, Dai WJ, Wölk B, Pichler W, Moradpour D, Brunner T, Cerny A.

Vaccine. 2004 Nov 15;23(1):58-68.

PMID:
15519708
24.

A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals.

Engler OB, Strasser I, Naisbitt DJ, Cerny A, Pichler WJ.

Toxicology. 2004 Apr 1;197(1):47-56.

PMID:
15003333
25.

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

Hunziker IP, Zurbriggen R, Glueck R, Engler OB, Reichen J, Dai WJ, Pichler WJ, Cerny A.

Mol Immunol. 2001 Dec;38(6):475-84.

PMID:
11741697
26.

Peptide vaccines against hepatitis B virus: from animal model to human studies.

Engler OB, Dai WJ, Sette A, Hunziker IP, Reichen J, Pichler WJ, Cerny A.

Mol Immunol. 2001 Dec;38(6):457-65. Review.

PMID:
11741695

Supplemental Content

Loading ...
Support Center